Cutting edge assessment of the impact of autoimmunity on female reproductive success

Journal of Autoimmunity

Volumn 38, Issue 2-3, 2012, Pages

  Gleicher, Norbert ^a,b,c   Weghofer, Andrea ^a,d   Barad, David H ^a,b,e  

^a CENTER FOR HUMAN REPRODUCTION   (United States)

^b Foundation for Reproductive Medicine   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Autoimmunity; Female infertility; FMR1 (fragile X) gene; Ovarian reserve

Indexed keywords

BONE MORPHOGENETIC PROTEIN 15; FRAGILE X MENTAL RETARDATION PROTEIN; TRANSCRIPTION FACTOR FOXP3;

ANEUPLOIDY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CHROMOSOME XQ; CLINICAL ASSESSMENT; FEMALE FERTILITY; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GENOTYPE; HIGH RISK PATIENT; HUMAN; IMMUNOLOGICAL TOLERANCE; INFERTILITY THERAPY; IPEX SYNDROME; NIDATION; OVARIAN RESERVE; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REPRODUCTIVE SUCCESS; REVIEW; SPONTANEOUS ABORTION; SYSTEMATIC REVIEW; TURNER SYNDROME; X CHROMOSOME LINKED DISORDER;

ANEUPLOIDY; AUTOIMMUNITY; CHROMOSOMES, HUMAN, X; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; HUMANS; IMMUNE TOLERANCE; INFERTILITY; PREGNANCY; PREVALENCE; REPRODUCTION;

EID: 84858746281     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2011.05.016     Document Type: Review

References (82)

1. Balasch J., Cervera R. Bidirectional effects on autoimmunity and reproduction. Hum Reprod Update 2008, 14:359-366.
2. Cline A.M., Kutteh W.H. Is there a role of autoimmunity in implantation failure after in-vitro fertilization?. Curr Opin Obstet Gynecol 2009, 21:291-295.
3. Gleicher N., Pratt D., Dudkiewicz A. What do we really know about autoantibody antibodies and reproductive failure: a critical review. Autoimmunity 1993, 16:115-1404.
4. Gleicher N., Weghofer A., Barad D. Female infertility due to abnormal autoimmunity: frequently overlooked and greatly under appreciated. Part I. Expert Rev Obstet Gynecol 2007, 2:453-464.
5. Gleicher N., Weghofer A., Barad D. Female infertility due to abnormal autoimmunity: frequently overlooked and greatly under appreciated. Part II. Expert Rev Obstet Gynecol 2007, 2:465-475.
6. Gleicher N., Vidali A., Karande V. The immunological " Wars of Roses" : disagreements amongst reproductive immunologists. Hum Reprod 2002, 17:539-542.
7. Gleicher N., Weghofer A., Lee I.H., Barad D.H. FMR1 genotype with autoimmunity-associated polycystic ovary-like phenotype and decreased pregnancy chance. PLoS ONE 2010, 5(12):e15303.
8. Guleria I., Sayegh M.H. Maternal acceptance of the fetus: true human tolerance. J Immunol 2007, 178:3345-3351.
9. Gleicher N. Why much of the pathophysiology of preeclampsia-eclampsia must be of an autoimmune nature. Am J Obstet Gynecol 2007, 196(1). 5.e1-7.
10. Gleicher N. Missed immunological opportunities in pregnancies. Expert Rev Clin Immunol 2008, 4:1-3.
11. Gleicher N. Graft-versus-host disease and immunologic rejection: implications for diagnosis and treatments of pregnancy complications. Expert Rev Obstet Gynecol 2008, 3:37-49.
12. Lubbe F., Butler W.S., Liggins G.C. The lupus-anticoagulant: clinical and obstetric implications. N Z Med J 1984, 97:398-402.
13. Gleicher N., Friberg J. IgM gammopathy and lupus anticoagulant syndrome in habitual aborters. JAMA 1985, 253:3278-3281.
14. Borchers A.T., Naguwa S.M., Keen C.L., Gershwin M.E. The Implications of autoimmunity and pregnancy. J Autoimmun 2010, 34:J287-J299.
15. Gleicher N. Reproductive failure prior to the onset of clinical autoimmune disease. Rheumatology 1999, 38:485-487.
16. Hornstein M. Antiphospholipid antibodies in patients undergoing IVF: the data do not support testing. Fertil Steril 2000, 74:635-636.
17. Hill J.A. " It's not what you don't know that makes you look like a fool. It's what you do know that ain't so." -Appalachian Mountain Proverb. Fertil Steril 2000, 74:637-638.
18. Scott R.T. Déjà vu all over again. Fertil Steril 2000, 74:639-640.
19. Medawar P.B. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates: prevention of allogeneic fetal rejection by tryptophan catabolism. Symp Soc Exp Biol 1953, 7:320-338.
20. Starzl T.E., Demetris A.J., Murase N., Ildstad S., Ricordi C., Trucco M. Cell migration, chimerism, and graft acceptance. Lancet 1992, 339:1579-1582.
21. Gleicher N. Pregnancy-related cell traffic, microchimerism and autoimmunity: the possibility of reducing autoimmune disease prevalence. Expert Rev Obstet Gynecol 2007, 2:341-345.
22. Gleicher N., Barad D.H. Gender as risk factor for autoimmune diseases. J Autoimmun 2007, 28:1-6.
23. Corthay A. How do regulatory T cells work?. Scand J Immunol 2009, 70:326-336.
24. + T cells. CurrOpinImmunol 2009, 21:281-285.
25. Wan Y.Y., Flavell R.A. How diverse-CD4 effector T cells and their functions. J Molec Cell Biol 2009, 1:20-36.
26. Zheng Y., Rudensky A.Y. Foxp3 in control of the regulatory T cell lineage. Nat Immunol 2007, 8:456-462.
27. Torgerson T.R., Ochs H.D. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: fork head box protein 3 mutations and lack of regulatory T cells. J Allergy Clin Immunol 2007, 120:744-759. [quiz 751-752].
28. + regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod 2004, 10:347-353.
29. Hekkinen J., Mottonen M., Alanen A., Lassila O. Phenotypic characterization of regulatory T cells in the human decidua. Clin Exp Immunol 2004, 136:373-378.
30. +regulatory T cell subset. Immunol 2004, 112:38-43.
31. highregulatory T cells and FOXP3 expression in unexplained recurrent spontaneous abortion patients. Fertil Steril 2010, 94:2244-2247.
32. Takakuwa K., Honda K., Yokoo T., Hataya I., Tamura M., Tanaka K. Molecular genetic studies on the compatibility of HLA class II alleles in patients with unexplained recurrent miscarriage in the Japanese population. Clin Immunol 2006, 118:101-107.
33. Nelson J.L., Hughes K.A., Smith A.G., Nisperos B.B., Branchaud A.M., Hansen J.A. Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N Engl J Med 1993, 329:466-471.
34. Navarro V., Herrine S., Katopes C., Colombe B., Spain C.V. The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: an analysis of the OPTN database. Liver Transpl 2006, 12:652-658.
35. Lan X., Zhang M.M., Pu C.L., Guo C.B., kang Q., Li Y.C., et al. Impact of human leukocyte antigens mismatching on outcomes of liver transplantation: a meta-analysis. World J Gastroenterol 2010, 16:3457-3464.
36. Gleicher N. Does the immune system induce labor? Lessons from preterm deliveries in women with autoimmune diseases. Clin Rev Allergy Immunol 2010, 39:194-206.
37. Biggar R.J., Poulsen G., Melbye M., Ng J., Boyd H.A. Spontaneous labor onset: is it immunologically mediated?. Am J Obstet Gynecol 2010, 202:268. e1-7.
38. Klein K., Worda C., Stammler-Safar M., Husslein P., Gleicher N., Weghofer A. Does fetal sex influence the risk of preterm delivery in dichorionic twin pregnancies after spontaneous conception?. Twin Res Hum Genet 2010, 13:495-500.
39. Weghofer A., Klein K., Stammler-Safar M., Worda C., Barad D.H., Husslein P., et al. The impact of fetal gender on prematurity in dichorionic twin gestation after in vitro fertilization. Reprod Biol Endocrinol 2010, 8:57.
40. Clark D.A. Immunological factors in pregnancy wastage: fact or fiction. Am J ReprodImmunol 2008, 59:277-300.
41. Gleicher N. Postpartum depression, an autoimmune disease?. Autoimmune Rev 2007, 6:572-576.
42. Gleicher N., Elkayam U. Peripartum cardiomyopathy, an autoimmune manifestation of allograft rejection?. Autoimmune Rev 2009, 8:384-387.
43. Geva E., Amit A., Lerner-Geva L., Lessing J.B. Autoimmunity and reproduction. Fertil Steril 1997, 67:599-611.
44. Luborsky J., Lianes B., Davies S., Binor Z., Radwanska E., Pong R. Ovarian autoimmunity: greater frequency of autoantibodies in premature menopause and unexplained infertility than in the general population. Clin Immunol 1999, 90:368-374.
45. Tomer Y., Shoenfeld J. The significance of natural autoantibodies. Immunol Invest 1988, 17:342-389.
46. Kay A., Bash F. Subfertility before and after development of rheumatoid arthritis in women. Ann Rheum Dis 1965, 24:169-173.
47. Nelson J.L., Koepsell T.D., Dugowson C.E., Voigt L.F., Daling J.R., Hansen J.A. Fecundity before disease onset in women with rheumatoid arthritis. Arthritis Rheum 1993, 36:7-14.
48. Silman A.J., Black C. Increased incidence of spontaneous abortion and infertility in women with scleroderma before disease onset: a controlled study. Ann Rheum 1988, 47:441-444.
49. Davidson A., Diamond B. Autoimmune diseases. N Engl J Med 2001, 345:340-350.
50. Poppe K., Velkeniers B., Glinoer D. The role of thyroid autoimmunity in fertility and pregnancy. Nat Clin Pract Endocrinol Metab 2008, 4:394-405.
51. Nikolaou D., Templeton A. Early ovarian ageing: a hypothesis. Detection and clinical relevance. Hum Reprod 2003, 18:1137-1139.
52. Barad D., Weghofer A., Gleicher N. Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function. Obstet Gynecol 2007, 109:1404-1410.
53. Gleicher N., Weghofer A., Oktay K., Barad D. Do etiologies of premature ovarian aging (POA) mimic those of premature ovarian failure (POF)?. Hum Reprod 2009, 24:2395-2400.
54. Pandey M.K., Rani R., Agrawal S. An update in recurrent spontaneous abortion. Arch Gynecol Obstet 2005, 272:95-108.
55. Gleicher N., Weghofer A., Barad D.H. Do chromosomally abnormal pregnancies really preclude autoimmune etiologies of spontaneous miscarriages?. Autoimmune Rev 2011, 10:361-363.
56. Canfiedl V.C., Daiger S.P., Gambello M., Hashmi S.S., King T., Noblin S.J., et al. Survival of Texas infants born with trisomies 21, 18, and 13. Am J Med Genet 2010, 152A:36-366.
57. Larizza D., Cacaterra V., Martinetti M. Autoimmune stigmata in Turner syndrome: when lacks an X chromosome. J Autoimmun 2009, 33:25-30.
58. Valloton M.B., Forbes A.P. Autoimmunity in gonadal dysgenesis and Klinefelter's syndrome. Lancet 1967, i:648-651.
59. Cassidy S.B., Niblack G.D., Lorber C.A., Mann J.M., Engel E. HLA frequencies, diabetes mellitus and autoimmunity in Turner's patients and their relatives. Ann Genet 1978, 21:203-208.
60. Pessach I., Notarangelo L.D. X-linked primary immunodeficiency as a bridge to better understanding X-chromosome related autoimmunity. J Autoimmun 2009, 33:17-24.
61. Persani L., Rossetti R., Cacciatore C., Bonomi M. Primary ovarian insufficiency: X chromosome defects and autoimmunity. J Autoimmun 2009, 33:35-41.
62. + regulatory T cells. Nat Immunol 2003, 4:330-336.
63. Sakaguchi S., Yamaguchi T., Nomura T., Ono M. Regulatory T cells and immune tolerance. Cell 2008, 133:775-787.
64. Notarangelo lanzi L.D., Lanzi G., Peron S., Durandy A. Defects of class-switch recombination. J Allergy Clin Immunol 2006, 117:855-864.
65. Sybert P.V., McCauley E. Turner's syndrome. N Engl J Med 2004, 351:1227-1238.
66. Toniolo D. X-linked premature ovarian failure. Curr Opin Genet Dev 2006, 16:293-300.
67. Zinn A.R., Tonk V.S., Chen Z., Flejter W.L., Gardner H.A., Guerra R., et al. Evidence for a Turner syndrome locus or loci at Xp11.2-p22.1. Am J Hum Genet 1998, 63:1757-1766.
68. Therman E., Laxova R. The critical region on the human Xq. Hum Genet 1990, 85:455-461.
69. Rizzolio F., Bione S., Sala C., Coegan M., Gentile M., Gregato G., et al. Chromosomal rearrangements in Xq and premature ovarian failure: mapping of 25 new cases and review of the literature. Hum Reprod 2006, 21:1477-1483.
70. Rizzolio F., Pramparo T., Sala C., Zuffardi O., De Santis L., Rabellotti E., et al. Epigenetic analysis of the critical region I for premature ovarian failure: demonstration of a highly heterochromatic domain on the long arm of the mammalian X chromosome. J Med Genet 2009, 46:585-592.
71. Fialkow P.J. Autoimmunity and chromosomal aberrations. Am J Hum Genet 1966, 18:93-108.
72. Wittenberger M.D., Hagerman R.J., Sherman S.L., McConkie-Rosell A., Welt C.K., Rebar R.W., et al. The FMR1 premutation and reproduction. Fertil Steril 2006, 87:456-465.
73. D'Hulst C., Kooy R.F. Fragile X syndrome: from molecular genetics to therapy. J Med Genet 2009, 46:577-584.
74. Gleicher N., Weghofer A., Barad D.H. A pilot study of premature ovarian senescence: I. Correlation of triple CGG repeats on the FMR1 gene to ovarian reserve parameters FSH and anti-Müllerian hormone. Fertil Steril 2009, 91:1700-1706.
75. Gleicher N., Weghofer A., Barad D.H. A pilots study of premature ovarian senescence: II Different genotype and phenotype for genetic and autoimmune etiologies. Fertil Steril 2009, 91:1707-1711.
76. Gleicher N., Weghofer A., Oktay K., Barad D.H. Correlation of triple repeats on the FMR1 (fragile X) gene to ovarian reserve: a new infertility test?. Acta Obstet Gynecol Scand 2009, 88:1024-1030.
77. Gleicher N., Weghofer A., Oktay K., Barad D.H. Can the FMR1 (fragile X) gene serve as predictor of response to ovarian stimulation?. Reprod Sci 2009, 16:462-467.
78. Gleicher N., Weghofer A., Oktay K., Barad D.H. Relevance of triple CGG repeats on the FMR1 gene to ovarian reserve. Repro Biomed Online 2009, 19:385-390.
79. Gleicher N., Weghofer A., Barad D.H. Effects of race/ethnicity on triple CGG counts in the FMR1 gene in infertile women and egg donors. Repro Biomed Online 2010, 20:485-491.
80. Gleicher N., Weghofer A., Barad D.H. Ovarian reserve determinations suggest new function of FMR1 (fragile X) gene in regulating ovarian aging. Repro Biomed Online 2010, 20:755-768.
81. Gleicher N., Barad D.H. The FMR1 gene as regulator of ovarian recruitment and ovarian reserve. Obstet Gynecol Surv 2010, 65:523-530.
82. Barad D.H., Weghofer A., Goyal A., Gleicher N. Further refinement in defining the effect of heterozygous-abnormal CGG counts on the FMR1 (fragile X) gene: definition of distinct subgroup of PCOS patients, based on normal/low genotype. Fertil Steril 2009, 92(Suppl 1):S105.